Sun Pharmaceutical Industries Ltd.

Financial

	Sun Pharma Inds.	Cipla	Dr. Reddy's Lab
Operational Metrics
Pharmaceutical Sector
Number of ANDA's Filed in USA	650.0 .	284.0 .	361.0 .
Number of ANDA's Approved By USFDA	541.0 .	211.0 .	288.0 .
Domestic Sales Growth - YoY	12.4 %	11.6 %	11.1 %
US DMF Filings	518.0 .	2472.0 .	n/a
US DMF Approval	397.0 .	n/a	n/a
R&D as a % of Total Sales	6.3 %	6.3 %	8.5 %
Financials
5 yr Average ROE	10.31 %	13.9 %	14.9 %
5yr average Equity Multiplier	1.37	1.25	1.41
5yr Average Asset Turnover Ratio	0.55	0.78	0.77
5yr Avg Net Profit Margin	13.53 %	14.31 %	14.03 %
Price to Book	5.53	3.89	3.3
P/E	36.53	22.99	19.56
5yr Avg Cash Conversion Cycle	-31.93 Days	-4.31 Days	64.1 Days
Inventory Days	60.94 Days	57.83 Days	75.39 Days
Days Receivable	85.38 Days	50.64 Days	99.54 Days
Days Payable	165.78 Days	105.99 Days	102.35 Days
5yr Average Interest Coverage Ratio	35.55	53.73	34.06
5yr Avg ROCE	16.04 %	19.36 %	19.83 %
5yr Avg Operating Profit Margin	24.95 %	23.02 %	21.19 %
5 yr average Debt to Equity	0.09	0.03	0.12
5yr CAGR Net Profit	20.53 %	17.0 %	22.45 %
5yr Average Return on Assets	7.59 %	11.19 %	10.71 %
Shareholdings
Promoter Holding	54.48 %	29.2 %	26.64 %
Share Pledged by Promoters	0.88 %	0.0	0.0
Change in Promoter Holding (3 Yrs)	0.0	-4.43 %	-0.08 %
Change in Mutual Fund Holding (3 Yrs)	0.58 %	6.6 %	-1.23 %

Business

	Sun Pharma Inds.	Cipla	Dr. Reddy's Lab
Product Wise Break-Up	Product Wise Break-Up India Branded Generics 32.0 US Formulations 30.0 Emerging Market 17.0 Western Europe & Other Markets 16.0 Active Pharmaceutical Ingredient (API) 5.0 New ventures 0 Pharmaceuticals 0 Proprietary Products 0 Global Generics 0 0	Product Wise Break-Up Pharmaceutical 95.75 India Branded Generics 0 0 Proprietary Products 0 New ventures 4.25 Global Generics 0 Emerging Market 0 Active Pharmaceutical Ingredient (API) 0 US Formulations 0 Western Europe & Other Markets 0	Product Wise Break-Up Pharmaceuticals 0 India Branded Generics 0 Pharmaceutical 13.52 Proprietary 0.17 New ventures 0 Formulations 86.31 Emerging Market 0 Active Pharmaceutical Ingredient (API) 0 US Formulations 0 Western Europe & Other Markets 0
Therapeutic Area Wise Break-Up - Domestic	Therapeutic Area Wise Break-Up - Domestic Central Nervous System (CNS) 20.0 Cardiac Science 17.0 Gastro Intestinal 14.0 Anti - Diabetes 8.0 Pain Management 7.0 Anti-Infective 6.0 Respiratory Systems 5.0 Vitamins / Minerals / Nutrients 5.0 Gynecology 4.0 Dermatology 4.0 Ophthalmology 3.0 Urology 3.0 Anti-infectives 0 Cardiac 0 Gastro Intestinal 0 Antivirals 0 Derma 0 Neuro /CNS 0 Gynaec. 0 Vitamins 0 Antineoplast 0 Opthal/Otologicals 0 Oncology 0 Anti Diabetic 0 Others 4.0	Therapeutic Area Wise Break-Up - Domestic Urology 4.7 Anti-Infective 14.0 Cardiac Science 0 Vitamins 0 Vitamins / Minerals / Nutrients 0 Central Nervous System (CNS) 0 Ophthalmology 0 Pain Management 0 Cardiac Science 11.4 Dermatology 0 Anti-Infective 0 Respiratory Systems 0 Anti - Diabetes 0 Gynecology 0 Gastro Intestinal 5.4 Ophthalmology 3.0 Anti - Diabetes 5.6 Antivirals 0 Derma 3.3 Antineoplast 0 Central Nervous System (CNS) 3.3 Gynaec. 0 Oncology 0 Others 49.3	-
Location Wise Break-Up	Location Wise Break-Up USA 33.26 India 32.24 Emerging Market 19.35 Rest of the World 15.15 SAGA 0 Europe 0 Global API 0 North America 0 Russia 0	Location Wise Break-Up Russia 0 North America 29.0 Europe 12.0 India 42.0 SAGA 14.0 Global API 2.0 Emerging Market 0 USA 0 Rest of the World 0 Others 1.0	Location Wise Break-Up Russia 7.99 North America 0 Europe 0 India 17.36 SAGA 0 Global API 0 Emerging Market 0 USA 48.56 Rest of the World 0 Others 26.09

Sun Pharmaceutical Industries Ltd.

Sun Pharmaceutical Industries Ltd.

SIGN UP FOR FREE